The inhibitory role of lactacystin and β-lactacystin on T-cell activation and proliferation

Acta Biochimica et Biophysica Sinica

Volumn 36, Issue 2, 2004, Pages 123-127

  Song, Peng Hong ^a   Xie, Hai Yang ^a   Zheng, Shu Sen ^a   Wu, Jian ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Immunosuppression; Proteasome; T cells activation

Indexed keywords

BETA LACTACYSTIN; BROXURIDINE; CD3 ANTIGEN; DIPEPTIDYL PEPTIDASE IV; INTERLEUKIN 12; INTERLEUKIN 2 RECEPTOR; LACTACYSTIN; PROTEASOME INHIBITOR; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; CELL PROLIFERATION; DOWN REGULATION; DRUG EFFECT; DRUG SCREENING; FLOW CYTOMETRY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE ACTIVATION;

EID: 16544367462     PISSN: 05829879     EISSN: None     Source Type: Journal    
DOI: 10.1093/abbs/36.2.123     Document Type: Article

References (20)

1. Tanahashi N, Murakami Y, Minami Y, Shimbara N, Hendil KB, Tanaka K. Hybrid proteasomes. Induction by interferon-γ and contribution to ATP-dependent proteolysis. J Biol Chem, 2000, 275(19): 14336-14345
2. Voges D, Zwickl P, Baumeister W. The 26S proteasome: A molecular machine designed for controlled proteolysis. Annu Rev Biochem, 1999, 68: 1015-1068
3. Sijts A, Sun Y, Janek K, Kral S, Paschen A, Schadendorf D, Kloetzel PM. The role of the proteasome activator PA28 in MHC class I antigen processing. Mol Immunol, 2002, 39(3-4): 165-169
4. Dick LR, Cruikshank AA, Destree AT, Grenier L, McCormack TA, Melandri FD, Nunes SL et al. Mechanistic studies on the inactivation of the proteasome by lactacystin in cultured cells. J Biol Chem, 1997, 272(1): 182-188
5. Tanaka K, Molecular biology of the proteasome. Biochem Biophys Res Commun, 1998, 247(3): 537-541
6. Tanaka K, Chiba T, The proteasome: A protein-destroying machine. Genes Cells, 1998, 3(8): 499-510
7. Rechsteiner M, Realini C, Ustrell V. The proteasome activator 11S REG (PA28) and class I antigen presentation. Biochem J, 2000, 345(Pt1): 1-15
8. Schwarz K, de Giuli R, Schmidtke G, Kostka S, van den Broek M, Kim KB, Crews CM et al. The selective proteasome inhibitors lactacystin and epoxomicin can be used to either up-or down-regulate antigen presentation at nontoxic doses. J Immunol, 2000, 164(12): 6147-6157
9. Niedermann G, Geier E, Lucchiari-Hartz M, Hitziger N, Ramsperger A, Eichmann K. The specificity of proteasomes: Impact on MHC class I processing and presentation of antigens. Immunol Rev, 1999, 172: 29-48
10. Fenteany G, Standaert RF, Lane WS, Choi S, Corey EJ, Schreiber SL. Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin. Science, 1995, 268(5211): 726-731
11. Craston R, Koh M, Mc Dermott A, Ray N, Prentice HG, Lowdell MW. Temporal dynamics of CD69 expression on lymphoid cells. J Immunol Methods, 1997, 209(1): 37-45
12. Russell SM, Keegan AD, Harada N, Nakamura Y, Noguchi M, Leland P, Friedmann MC et al. Interleukin-2 receptor gamma chain: A functional component of the interleukin-4 receptor. Science, 1993, 262(5141): 1880-1883
13. Ahn K, Erlander M, Leturcq D, Peterson PA, Früh K, Yang Y. In vivo characterization of the proteasome regulator PA28. J Biol Chem, 1996, 271 (30): 18237-18242
14. Wilk S, Chen WE, Magnusson RP. Properties of the beta subunit of the proteasome activator PA28 (11S REG). Arch Biochem Biophys, 2000, 384 (1): 174-180
15. Kloetzel PM, Soza A, Stohwasser R. The role of the proteasome system and the proteasome activator PA28 complex in the cellular immune response. Biol Chem, 1999, 380(3): 293-297
16. Wilk S, Chen WE, Magnusson RP. Modulators of the activation of the proteasome by PA28 (11S reg). Mol Biol Rep, 1999, 26(1-2): 39-44
17. Li N, Lerea KM, Etlinger JD. Phosphorylation of the proteasome activator PA28 is required for proteasome activation. Biochem Biophys Res Commun, 1996, 225(3): 855-860
18. Wang X, Omura S, Szweda LI, Yang Y, Berard J, Seminaro J, Wu J. Rapamycin inhibits proteasome activator expression and proteasome activity. Eur J Immunol 1997, 27(11): 2781-2786
19. Stohwasser R, Soza A, Eggers M, Koszinowski UH, Kloetzel PM. PA28 alphabeta double and PA28beta single transfectant mouse B8 cell lines reveal enhanced presentation of a mouse cytomegalovirus (MCMV) pp89 MHC class I epitope. Mol Immunol, 2000, 37(1-2): 13-19
20. Zhou GY ed. Principles of Immunology. Shanghai Science and Technology Press, 2000